Interventional cardiology deals with the treatment of the heart related diseases such as coronary artery disease, congenital heart defect and aneurysm through catheter based devices. The process involves the insertion of catheter into large peripheral artery or vein to perform surgical process. Interventional cardiology provides fast recovery, controlled bleeding and short hospital stay. The interventional cardiology market has witnessed constant development from bare metal stent to bio-absorbable stent. Intervention cardiology devices include stents, catheters, guide wires, filters and balloons. According to Center of Disease Control and Prevention, in 2018 approximately 40,000 children are suffering from coronary heart disease in the U.S. The market is expected to register a CAGR of xx % during the forecast period of 2018 to 2025.
Geographically, North America is leading in the interventional cardiology devices market owing to large geriatric population and sedentary life-style causing cardiovascular disorders. In 2016, as per Population Reference Bureau, approximately 40 million of age 60 and above are suffering from cardiovascular diseases and the prevalence is expected to reach 89 million by 2050 in the U.S alone, followed by Europe. Asia Pacific is expected to expand significantly in the near future because emerging economies such as China and India owing to its large population base are suffering from cardiovascular diseases and diabetes. The continuous increase in healthcare expenditure and increase in geriatric population are also fueling the growth of interventional cardiology devices market.
Click Here to Get Sample Premium Report : https://www.trendsmarketresearch.com/report/sample/3631
The major players operating in the interventional cardiology devices include Boston Scientific Corporation, Cook Medical, Medtronic Plc, Cardinal Health, Terumo Medical Corporation, Abbott Scientific and B Braun Melsungen A.G. The key players are focusing on acquisition to increase its portfolio of product offerings. In this direction, in 2017, Abbott acquired St Jude Medical to increase in product pipeline. St Jude Medical is into atrial fibrillation, heart failure, chronic pain and structural heart devices manufacturing, which will supplement the products of the Abbott.
Get Request for Table of Contents: https://www.trendsmarketresearch.com/report/requesttoc/3631
Global Interventional Cardiology Devices Market: Segmentation
By Product Type
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
Intravascular Ultrasound System
Inferior Vena Cava (IVC) Filter
Percutaneous Transluminal Coronary Angiography (PTCA) Guide Wires
Left Atrial Appendage (LAA) Device
Increased prevalence of cardiovascular disorders is expected to fuel the growth of interventional cardiology devices market
The overall world population is witnessing increase in proportion of geriatric population and obesity which is causing numerous heart related diseases. For instance, according to the United Nations report, around xx million people of age 65 and above in 2015 across the globe are suffering from heart related disorders and it is expected to reach xx billion by 2050. The major drivers responsible for the growth of the market are the advancement in the healthcare research, increase in the demand of minimal invasive procedures and increasing patient awareness. The increase in geriatric population coupled with obesity and lifestyle patterns leads to the increase in coronary artery disease. In 2017, American Heart Association reported 36,000 deaths due to coronary artery disease in the U.S alone. Continuous innovations in interventional cardiology devices such as new generation drug eluting balloons and bio-absorbable stents are expected to further support the growth in the interventional cardiology devices market. However the market is hindered by product recalls and high cost of manufacturing the devices.
You can Buy This Report from Here @ https://www.trendsmarketresearch.com/checkout/3631/Single